Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

Why This Beef Stew Deserves A Spot In Your Weekly Rotation This isn’t your average beef stew—it’s a rich, creamy, ...

I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...

Madrigal Pharmaceuticals MDGL reported first-quarter 2025 loss of $3.32 per share, narrower than the Zacks Consensus Estimate ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...